Patents by Inventor Alison Brownlie

Alison Brownlie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions employing a novel stearoyl-CoA desaturase-hSCD5
    Publication number: 20070238648
    Abstract: A cDNA encoding a novel human stearoy-CoA desaturase (dubbed “hSCD5”) as well as vectors and cells comprising such polynucleotide are disclosed. Also described arc assay methods for determining the ability of small molecules and other chemical agents to increase or decrease he enzymatic activity and/or gene expression level of hSCD5 as well as processes for using such agents to treat, prevent or diagnose a variety of diseases and other conditions.
    Type: Application
    Filed: June 4, 2007
    Publication date: October 11, 2007
    Inventor: Alison Brownlie
  • Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
    Publication number: 20050256033
    Abstract: The use of screening assays based on the role of human stearoyl-CoA desaturase-1 (“hSCD1”) in human diseases, disorders or conditions relating to serum levels of triglyceride, VLDL, HDL, LDL, total cholesterol, or production of secretions from mucous membranes, monounsaturated fatty acids, wax esters, and the like, is disclosed. Also disclosed are conventions useful in the prevention and/or treatment of such diseases.
    Type: Application
    Filed: July 11, 2005
    Publication date: November 17, 2005
    Inventors: Michael Hayden, Alison Brownlie, James Ntambi, Makoto Miyazaki, Mark Gray-Keller, Alan Attie
  • Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
    Publication number: 20050250160
    Abstract: The use of screening assays based on the role of human stearoyl-CoA desaturase-1 (“hSCD1”) in human diseases, disorders or conditions relating to serum levels of triglyceride, VLDL, HDL, LDL, total cholesterol, or production of secretions from mucous membranes, monounsaturated fatty acids, wax esters, and the like, is disclosed. Also disclosed are conventions useful in the prevention and/or treatment of such diseases.
    Type: Application
    Filed: July 11, 2005
    Publication date: November 10, 2005
    Inventors: Michael Hayden, Alison Brownlie, James Ntambi, Makoto Miyazaki, Mark Gray-Keller, Alan Attie